-
Something wrong with this record ?
Juxtaglomerular cell tumor: a morphological, immunohistochemical and genetic study of six cases
N Kuroda, S Maris, FA Monzon, PH Tan, A Thomas, FB Petersson, Z Gatalica, A Ghazalpour, RP Bender, P Grossmann, M Michal, M Svajdler, Z Ovcak, M Hora, O Hes
Language English Country United States
Grant support
NT12010
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Medline Complete (EBSCOhost)
from 2012-09-01 to 2015-07-31
- MeSH
- beta Catenin MeSH
- Cytoplasmic Granules MeSH
- Adult MeSH
- Immunohistochemistry MeSH
- Juxtaglomerular Apparatus MeSH
- Karyotyping MeSH
- Humans MeSH
- Young Adult MeSH
- Proto-Oncogene Proteins c-kit MeSH
- Renin MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Young Adult MeSH
- Male MeSH
- Female MeSH
Juxtaglomerular cell tumors (JGCTs) are rare tumors characterized by renin synthesis, hyperaldosteronism and hypertension. A curious immunohistochemical overlap between JGCT and gastrointestinal stromal tumor (GIST) including the expression of vimentin, CD34, CD117, alpha-smooth muscle actin was previously reported, prompting us to further investigate JGCT and its phenotypic and molecular genetic characteristics. Virtual karyotyping showed gain of chromosomes 3, 4, 10, 13, 17 and 18 in one JGCT, and fluorescence in situ hybridization (FISH) study confirmed this multiple gain pattern. Additionally, loss of chromosome 9 was observed in four of six cases analyzed with FISH. A whole genome expression analysis revealed 415 up-regulated (including renin, and CD117) and 325 down-regulated genes between the 2 cases. The study confirmed earlier reports on the gain of chromosomes 4 and 10, and provided further evidence of up-regulation of the genes located on these 2 chromosomes. For the first time our study indicated the importance of the loss of chromosome 9 and loss of expression of several tumor suppressor genes located on this chromosome as possible pathogenetic events important in development of JGCT.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18038348
- 003
- CZ-PrNML
- 005
- 20220411124942.0
- 007
- ta
- 008
- 181121s2013 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.humpath.2012.04.006 $2 doi
- 035 __
- $a (PubMed)22939575
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kuroda N $u Kuroda, Naoto. Department of Diagnostic Pathology, Kochi Red Cross Hospital, Kochi 780-8562, Japan.
- 245 10
- $a Juxtaglomerular cell tumor: a morphological, immunohistochemical and genetic study of six cases / $c N Kuroda, S Maris, FA Monzon, PH Tan, A Thomas, FB Petersson, Z Gatalica, A Ghazalpour, RP Bender, P Grossmann, M Michal, M Svajdler, Z Ovcak, M Hora, O Hes
- 520 9_
- $a Juxtaglomerular cell tumors (JGCTs) are rare tumors characterized by renin synthesis, hyperaldosteronism and hypertension. A curious immunohistochemical overlap between JGCT and gastrointestinal stromal tumor (GIST) including the expression of vimentin, CD34, CD117, alpha-smooth muscle actin was previously reported, prompting us to further investigate JGCT and its phenotypic and molecular genetic characteristics. Virtual karyotyping showed gain of chromosomes 3, 4, 10, 13, 17 and 18 in one JGCT, and fluorescence in situ hybridization (FISH) study confirmed this multiple gain pattern. Additionally, loss of chromosome 9 was observed in four of six cases analyzed with FISH. A whole genome expression analysis revealed 415 up-regulated (including renin, and CD117) and 325 down-regulated genes between the 2 cases. The study confirmed earlier reports on the gain of chromosomes 4 and 10, and provided further evidence of up-regulation of the genes located on these 2 chromosomes. For the first time our study indicated the importance of the loss of chromosome 9 and loss of expression of several tumor suppressor genes located on this chromosome as possible pathogenetic events important in development of JGCT.<ovid:br /><ovid:br />Copyright © 2013 Elsevier Inc. All rights reserved.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a dospělí $7 D000328
- 650 02
- $a cytoplazmatická granula $7 D003594
- 650 02
- $a ženské pohlaví $7 D005260
- 650 02
- $a lidé $7 D006801
- 650 02
- $a imunohistochemie $7 D007150
- 650 02
- $a juxtaglomerulární aparát $7 D007606
- 650 02
- $a karyotypizace $7 D007621
- 650 02
- $a mužské pohlaví $7 D008297
- 650 02
- $a protoonkogenní proteiny c-kit $7 D019009
- 650 02
- $a renin $7 D012083
- 650 02
- $a mladý dospělý $7 D055815
- 650 02
- $a beta-katenin $7 D051176
- 700 1_
- $a Maris S
- 700 1_
- $a Monzon FA
- 700 1_
- $a Tan PH
- 700 1_
- $a Thomas A
- 700 1_
- $a Petersson FB
- 700 1_
- $a Gatalica Z
- 700 1_
- $a Ghazalpour A
- 700 1_
- $a Bender RP
- 700 1_
- $a Grossmann, Petr $7 xx0108998
- 700 1_
- $a Michal, Michal, $d 1959- $7 jn20001103501
- 700 1_
- $a Svajdler M
- 700 1_
- $a Ovcak Z
- 700 1_
- $a Hora, Milan, $d 1967- $7 mzk2004258359
- 700 1_
- $a Hes, Ondřej, $d 1968- $7 jn20001103502
- 773 0_
- $t Human Pathology $g Roč. 44, č. 1 (2013), s. 47-54 $p Hum Pathol $x 0046-8177 $w MED00002080
- 773 0_
- $p Hum Pathol $g 44(1):47-54, 2013 Jan
- 910 __
- $a ABA008 $y 4 $z 0
- 990 __
- $a 20181121103228 $b ABA008
- 991 __
- $a 20220411124940 $b ABA008
- 999 __
- $a ok $b bmc $g 1352891 $s 1035386
- BAS __
- $a 3
- BMC __
- $a 2013 $b 44 $c 1 $d 47-54 $x MED00002080 $i 0046-8177 $m Human pathology
- GRA __
- $a NT12010 $p MZ0
- LZP __
- $a NLK 2018/lp